Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Hepatitis C | Research article

Association of TGF-ß1 polymorphisms and chronic hepatitis C infection: a Meta-analysis

Authors: Pengfei Guo, Shuangyin Liu, Xiangru Sun, Longqin Xu

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Although several researches have reported the connection between the transforming growth factor-beta 1 (TGF-β1) gene polymorphisms and chronic hepatitis C virus (HCV) infection, the conclusions of these studies were not always consistent. Here, this paper proposed a meta-analysis to evaluate whether the TGF-ß1 gene polymorphisms, −509C/T (rs1800469), codon 10 T/C (rs1982073) and codon 25G/C (rs1800471), were associated with chronic HCV infection.

Methods

The summary odds ratios (ORs) of chronic HCV infected patients and controls with all SNPs were obtained by adaptive fixed or random effect model. A series of statistical tools were employed to guarantee the accuracy of related pooling ORs, including the Hardy-Weinberg equilibrium (HWE) test, sensitivity analysis and publication bias test.

Results

This paper analyzed 18 case-control studies in 17 articles which totally contains 2718 chronic HCV infection cases corresponding to 1964 controls. The results of the meta-analysis indicated that the −509C/T polymorphism effected an increased risk of chronic HCV infection in all gene models. More specifically by ethnicity stratification, the Egyptians shared the similar association with the above overall study. Moreover, the meta-fusion of healthy control studies showed that − 509 T allele carriers (TT + TA) had nearly 2.00 and 3.36 fold higher risk of chronic HCV infection in the total and Egyptian populations, respectively (OR = 2.004, 95% CI = 1.138–3.528, P = 0.016; OR = 3.363, 95% CI = 1.477–7.655, P = 0.004, respectively). However, our meta-analysis did not find any significant association between the codon 10 T/C or codon 25G/C polymorphisms and chronic HCV infection.

Conclusions

Our results suggested that the TGF-ß1–509C/T polymorphism may effect an increased risk of chronic HCV infection, especially in Egyptian population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107–15.CrossRef Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107–15.CrossRef
2.
go back to reference Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215–29.CrossRef Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215–29.CrossRef
3.
go back to reference Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. Jama. 2000;284:450–6.CrossRef Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. Jama. 2000;284:450–6.CrossRef
4.
go back to reference Bengsch B, Thimme R, Blum HE. Role of host genetic factors in the outcome of hepatitis C virus infection. Viruses. 2009;1:104–25.CrossRef Bengsch B, Thimme R, Blum HE. Role of host genetic factors in the outcome of hepatitis C virus infection. Viruses. 2009;1:104–25.CrossRef
5.
go back to reference Sun XR, Wu J, Shi KQ, Tang KF. Relationship between IL-10 gene -1082A/G and -592C/a polymorphisms and the risk of hepatitis C infection: a meta-analysis. J Viral Hepat. 2013;20:602–11.CrossRef Sun XR, Wu J, Shi KQ, Tang KF. Relationship between IL-10 gene -1082A/G and -592C/a polymorphisms and the risk of hepatitis C infection: a meta-analysis. J Viral Hepat. 2013;20:602–11.CrossRef
6.
go back to reference Mohy A, Fouad A. Role of transforming growth factor-beta1 in serum and - 509 C>T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients. Meta Gene. 2014;2:631–7.CrossRef Mohy A, Fouad A. Role of transforming growth factor-beta1 in serum and - 509 C>T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients. Meta Gene. 2014;2:631–7.CrossRef
7.
go back to reference Radwan MI, Pasha HF, Mohamed RH, Hussien HI, El-Khshab MN. Influence of transforming growth factor-beta1 and tumor necrosis factor-alpha genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. Cytokine. 2012;60:271–6.CrossRef Radwan MI, Pasha HF, Mohamed RH, Hussien HI, El-Khshab MN. Influence of transforming growth factor-beta1 and tumor necrosis factor-alpha genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. Cytokine. 2012;60:271–6.CrossRef
8.
go back to reference Schuppan D, Krebs A, Bauer M, Hahn EG. Hepatitis C and liver fibrosis. Cell Death Differ. 2003;10(Suppl 1):S59–67.CrossRef Schuppan D, Krebs A, Bauer M, Hahn EG. Hepatitis C and liver fibrosis. Cell Death Differ. 2003;10(Suppl 1):S59–67.CrossRef
9.
go back to reference Kondo Y, Ueno Y, Shimosegawa T. Dysfunction of immune systems and host genetic factors in hepatitis C virus infection with persistent Normal ALT. Hepat Res Treat. 2011;2011:713216.PubMedPubMedCentral Kondo Y, Ueno Y, Shimosegawa T. Dysfunction of immune systems and host genetic factors in hepatitis C virus infection with persistent Normal ALT. Hepat Res Treat. 2011;2011:713216.PubMedPubMedCentral
10.
go back to reference Fujii D, Brissenden JE, Derynck R, Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986;12:281–8.CrossRef Fujii D, Brissenden JE, Derynck R, Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986;12:281–8.CrossRef
11.
go back to reference Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93–7.CrossRef Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93–7.CrossRef
12.
go back to reference Ma J, Liu YC, Fang Y, Cao Y, Liu ZL. TGF-beta1 polymorphism 509 C>T is associated with an increased risk for hepatocellular carcinoma in HCV-infected patients. Genet Mol Res. 2015;14:4461–8.CrossRef Ma J, Liu YC, Fang Y, Cao Y, Liu ZL. TGF-beta1 polymorphism 509 C>T is associated with an increased risk for hepatocellular carcinoma in HCV-infected patients. Genet Mol Res. 2015;14:4461–8.CrossRef
13.
go back to reference Pasha HF, Radwan MI, Hagrass HA, Tantawy EA, Emara MH. Cytokines genes polymorphisms in chronic hepatitis C: impact on susceptibility to infection and response to therapy. Cytokine. 2013;61:478–84.CrossRef Pasha HF, Radwan MI, Hagrass HA, Tantawy EA, Emara MH. Cytokines genes polymorphisms in chronic hepatitis C: impact on susceptibility to infection and response to therapy. Cytokine. 2013;61:478–84.CrossRef
14.
go back to reference Kimura T, Saito T, Yoshimura M, Yixuan S, Baba M, et al. Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus. J Infect Dis. 2006;193:1371–4.CrossRef Kimura T, Saito T, Yoshimura M, Yixuan S, Baba M, et al. Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus. J Infect Dis. 2006;193:1371–4.CrossRef
15.
go back to reference Romani S, Azimzadeh P, Mohebbi SR, Kazemian S, Almasi S, et al. Investigation of transforming growth factor-beta1 gene polymorphisms among Iranian patients with chronic hepatitis C. Hepat Mon. 2011;11:901–6.CrossRef Romani S, Azimzadeh P, Mohebbi SR, Kazemian S, Almasi S, et al. Investigation of transforming growth factor-beta1 gene polymorphisms among Iranian patients with chronic hepatitis C. Hepat Mon. 2011;11:901–6.CrossRef
16.
go back to reference Imran M, Manzoor S, Parvaiz F. Predictive potential of IL-18 -607 and osteopontin −442 polymorphism in interferon-based therapy of HCV infection in the Pakistani population. Viral Immunol. 2014;27:404–11.CrossRef Imran M, Manzoor S, Parvaiz F. Predictive potential of IL-18 -607 and osteopontin −442 polymorphism in interferon-based therapy of HCV infection in the Pakistani population. Viral Immunol. 2014;27:404–11.CrossRef
17.
go back to reference Rebbani K, Ezzikouri S, Marchio A, Ababou M, Kitab B, et al. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population. Infect Genet Evol. 2014;26:1–7.CrossRef Rebbani K, Ezzikouri S, Marchio A, Ababou M, Kitab B, et al. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population. Infect Genet Evol. 2014;26:1–7.CrossRef
18.
go back to reference Armendariz-Borunda J, Rincon AR, Munoz-Valle JF, Bueno-Topete M, Oregon-Romero E, et al. Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential Correlation with pirfenidone treatment. J Investig Med. 2008;56:944–53.CrossRef Armendariz-Borunda J, Rincon AR, Munoz-Valle JF, Bueno-Topete M, Oregon-Romero E, et al. Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential Correlation with pirfenidone treatment. J Investig Med. 2008;56:944–53.CrossRef
19.
go back to reference Wang H, Mengsteab S, Tag CG, Gao CF, Hellerbrand C, et al. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol. 2005;11:1929–36.CrossRef Wang H, Mengsteab S, Tag CG, Gao CF, Hellerbrand C, et al. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol. 2005;11:1929–36.CrossRef
20.
go back to reference Fang J, Liu ZW, Han QY. Polymorphism of codon25 in signal peptide region of transforming growth factor beta 1 and its association with chronic hepatitis C virus infection. Zhonghua Gan Zang Bing Za Zhi. 2008;16:586–9.PubMed Fang J, Liu ZW, Han QY. Polymorphism of codon25 in signal peptide region of transforming growth factor beta 1 and its association with chronic hepatitis C virus infection. Zhonghua Gan Zang Bing Za Zhi. 2008;16:586–9.PubMed
21.
go back to reference Pereira FA, Pinheiro da Silva NN, Rodart IF, Carmo TM, Lemaire DC, et al. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol. 2008;80:58–64.CrossRef Pereira FA, Pinheiro da Silva NN, Rodart IF, Carmo TM, Lemaire DC, et al. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol. 2008;80:58–64.CrossRef
22.
go back to reference Suzuki S, Tanaka Y, Orito E, Sugauchi F, Hasegawa I, et al. Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2003;18:1139–43.CrossRef Suzuki S, Tanaka Y, Orito E, Sugauchi F, Hasegawa I, et al. Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2003;18:1139–43.CrossRef
23.
go back to reference Barrett S, Collins M, Kenny C, Ryan E, Keane CO, et al. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol. 2003;71:212–8.CrossRef Barrett S, Collins M, Kenny C, Ryan E, Keane CO, et al. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol. 2003;71:212–8.CrossRef
24.
go back to reference Larijani MS, Rad LN, Nikbin M, Bahiraei N, Javadi F, et al. Impact of TGF-beta1 gene polymorphism (rs1800469) on treatment response to Pegylated interferon/ribavirin in Iranian patients with hepatitis C. Clin Lab. 2016;62:609–14.PubMed Larijani MS, Rad LN, Nikbin M, Bahiraei N, Javadi F, et al. Impact of TGF-beta1 gene polymorphism (rs1800469) on treatment response to Pegylated interferon/ribavirin in Iranian patients with hepatitis C. Clin Lab. 2016;62:609–14.PubMed
25.
go back to reference Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E, et al. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A. 2003;100:4120–5.CrossRef Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E, et al. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A. 2003;100:4120–5.CrossRef
26.
go back to reference Vidigal PG, Germer JJ, Zein NN. Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol. 2002;36:271–7.CrossRef Vidigal PG, Germer JJ, Zein NN. Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol. 2002;36:271–7.CrossRef
27.
go back to reference Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014–20.CrossRef Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014–20.CrossRef
28.
go back to reference Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327:557–60.CrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327:557–60.CrossRef
29.
go back to reference Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315:629–34.CrossRef Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315:629–34.CrossRef
30.
go back to reference Zein NN, Germer JJ, El-Zayadi AR, Vidigal PG. Ethnic differences in polymorphisms of tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in patients with chronic hepatitis C virus infection. Am J Trop Med Hyg. 2004;70:434–7.CrossRef Zein NN, Germer JJ, El-Zayadi AR, Vidigal PG. Ethnic differences in polymorphisms of tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in patients with chronic hepatitis C virus infection. Am J Trop Med Hyg. 2004;70:434–7.CrossRef
31.
go back to reference Hu GR, Zheng BX, Liu ZF. Association between TGFB1 915G/C polymorphism and susceptibility to chronic hepatitis C virus infection: a meta-analysis. Biomed Rep. 2014;2:239–44.CrossRef Hu GR, Zheng BX, Liu ZF. Association between TGFB1 915G/C polymorphism and susceptibility to chronic hepatitis C virus infection: a meta-analysis. Biomed Rep. 2014;2:239–44.CrossRef
32.
go back to reference Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology. 2000;31:828–33.CrossRef Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology. 2000;31:828–33.CrossRef
33.
go back to reference Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta. 2002;316:83–94.CrossRef Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta. 2002;316:83–94.CrossRef
Metadata
Title
Association of TGF-ß1 polymorphisms and chronic hepatitis C infection: a Meta-analysis
Authors
Pengfei Guo
Shuangyin Liu
Xiangru Sun
Longqin Xu
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Hepatitis C
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4390-8

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue